These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10807873)

  • 1. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.
    Jormsjö S; Ye S; Moritz J; Walter DH; Dimmeler S; Zeiher AM; Henney A; Hamsten A; Eriksson P
    Circ Res; 2000 May; 86(9):998-1003. PubMed ID: 10807873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients.
    Jormsjö S; Whatling C; Walter DH; Zeiher AM; Hamsten A; Eriksson P
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1834-9. PubMed ID: 11701474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
    Lamblin N; Bauters C; Hermant X; Lablanche JM; Helbecque N; Amouyel P
    J Am Coll Cardiol; 2002 Jul; 40(1):43-8. PubMed ID: 12103254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of human matrix metalloproteinase-12 gene transcriptional activity by GM-CSF requires the AP-1 binding site in human U937 monocytic cells.
    Wu L; Tanimoto A; Murata Y; Fan J; Sasaguri Y; Watanabe T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):300-7. PubMed ID: 11444842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13).
    Pendás AM; Balbín M; Llano E; Jiménez MG; López-Otín C
    Genomics; 1997 Mar; 40(2):222-33. PubMed ID: 9119388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression.
    Medley TL; Cole TJ; Dart AM; Gatzka CD; Kingwell BA
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1479-84. PubMed ID: 15191941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.
    Zhang B; Ye S; Herrmann SM; Eriksson P; de Maat M; Evans A; Arveiler D; Luc G; Cambien F; Hamsten A; Watkins H; Henney AM
    Circulation; 1999 Apr; 99(14):1788-94. PubMed ID: 10199873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
    Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
    Maeda S; Haneda M; Guo B; Koya D; Hayashi K; Sugimoto T; Isshiki K; Yasuda H; Kashiwagi A; Kikkawa R
    Kidney Int; 2001 Oct; 60(4):1428-34. PubMed ID: 11576356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2G single nucleotide polymorphism (SNP) in the MMP-1 promoter contributes to high levels of MMP-1 transcription in MCF-7/ADR breast cancer cells.
    Tower GB; Coon CI; Brinckerhoff CE
    Breast Cancer Res Treat; 2003 Nov; 82(2):75-82. PubMed ID: 14692651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
    Mishra M; Flaga J; Kowluru RA
    J Cell Physiol; 2016 Aug; 231(8):1709-18. PubMed ID: 26599598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.
    Ye S
    Matrix Biol; 2000 Dec; 19(7):623-9. PubMed ID: 11102751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.
    Ye S; Watts GF; Mandalia S; Humphries SE; Henney AM
    Br Heart J; 1995 Mar; 73(3):209-15. PubMed ID: 7727178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients.
    Chen YH; Chau LY; Chen JW; Lin SJ
    Diabetes Care; 2008 Aug; 31(8):1615-20. PubMed ID: 18443197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
    Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
    Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels.
    Farzaneh-Far A; Davies JD; Braam LA; Spronk HM; Proudfoot D; Chan SW; O'Shaughnessy KM; Weissberg PL; Vermeer C; Shanahan CM
    J Biol Chem; 2001 Aug; 276(35):32466-73. PubMed ID: 11425864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD.
    Haq I; Lowrey GE; Kalsheker N; Johnson SR
    Thorax; 2011 Nov; 66(11):970-6. PubMed ID: 21730350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Analysis of a Novel Genome-Wide Association Study Signal in SMAD3 That Confers Protection From Coronary Artery Disease.
    Turner AW; Martinuk A; Silva A; Lau P; Nikpay M; Eriksson P; Folkersen L; Perisic L; Hedin U; Soubeyrand S; McPherson R
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):972-83. PubMed ID: 26966274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.